U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07936162) titled 'Immune Reconstitution and Clinical Prognosis Following Umbilical Cord Blood Transplantation' on Nov. 06.
Brief Summary: In this prospective randomized controlled trial of umbilical cord blood hematopoietic stem cell transplant recipients, post-transplant immune data will be collected from two groups. A composite immune risk score will be used to assess immune reconstitution for risk stratification and analyze its associations with clinical prognostic endpoints.
Study Start Date: Oct. 16
Study Type: INTERVENTIONAL
Condition:
Transplant-Related Disorder
Intervention:
BEHAVIORAL: Composite Immune Risk Score Stratification Notific...